Discovery of amivantamab (JNJ-61186372), a bispecific antibody targeting EGFR and MET.
J Biol Chem
; 296: 100641, 2021.
Article
in En
| MEDLINE
| ID: mdl-33839159
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antibodies, Bispecific
/
Carcinoma, Non-Small-Cell Lung
/
Proto-Oncogene Proteins c-met
/
Drug Discovery
/
Lung Neoplasms
Type of study:
Prognostic_studies
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
J Biol Chem
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: